D. E. Shaw & Co., Inc. Cel Sci Corp Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.11 - $1.85 $150,216 - $250,360	-135,330 Reduced 71.78%	53,215 $61,000
Q1 2024 May 15, 2024	BUY	$1.63 - $3.08 $135,242 - $255,550	82,971 Added 78.59%	188,545 $360,000
Q4 2023 Feb 14, 2024	BUY	$1.07 - $3.07 $74,946 - $215,032	70,043 Added 197.13%	105,574 $287,000
Q3 2023 Nov 14, 2023	SELL	$1.17 - $2.86 $19,603 - $47,919	-16,755 Reduced 32.04%	35,531 $44,000
Q2 2023 Aug 14, 2023	BUY	$2.11 - $2.83 $40,237 - $53,968	19,070 Added 57.41%	52,286 $126,000
Q1 2023 May 15, 2023	BUY	$2.17 - $3.13 $72,078 - $103,966	33,216 New	33,216 $77,000
Q2 2022 Aug 15, 2022	SELL	$2.58 - $4.99 $1.72 Million - $3.33 Million	-666,489 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.93 - $7.7 $161,369 - $316,169	41,061 Added 6.57%	666,489 $2.62 Million
Q4 2021 Feb 14, 2022	BUY	$7.1 - $12.82 $946,671 - $1.71 Million	133,334 Added 27.1%	625,428 $4.44 Million
Q3 2021 Nov 15, 2021	SELL	$7.64 - $12.49 $3.53 Million - $5.76 Million	-461,528 Reduced 48.4%	492,094 $5.41 Million
Q2 2021 Aug 16, 2021	SELL	$8.68 - $27.49 $2.45 Million - $7.76 Million	-282,160 Reduced 22.83%	953,622 $8.28 Million
Q1 2021 May 17, 2021	BUY	$12.0 - $27.64 $4.16 Million - $9.57 Million	346,266 Added 38.93%	1,235,782 $18.8 Million
Q4 2020 Feb 16, 2021	BUY	$11.05 - $16.62 $113,207 - $170,271	10,245 Added 1.17%	889,516 $10.4 Million
Q3 2020 Nov 16, 2020	SELL	$11.69 - $14.54 $530,527 - $659,868	-45,383 Reduced 4.91%	879,271 $11.2 Million
Q2 2020 Aug 14, 2020	BUY	$9.75 - $17.6 $1.17 Million - $2.11 Million	119,831 Added 14.89%	924,654 $13.8 Million
Q1 2020 May 15, 2020	BUY	$7.54 - $17.05 $4.77 Million - $10.8 Million	632,471 Added 366.96%	804,823 $9.29 Million
Q4 2019 Feb 14, 2020	BUY	$6.71 - $9.55 $545,147 - $775,880	81,244 Added 89.17%	172,352 $1.58 Million
Q3 2019 Nov 14, 2019	BUY	$6.0 - $9.6 $546,648 - $874,636	91,108 New	91,108 $815,000

Others Institutions Holding CVM

# of Institutions

Shares Held

Call Options Held

27.1K

Put Options Held

150K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account